These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17452016)

  • 21. [Advances in the development of neutralizing therapies for sepsis].
    Florencia Henning M; Garda H; Bakás L
    Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide: an endotoxin or an exogenous hormone?
    Marshall JC
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S470-80. PubMed ID: 16237650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of small-molecule endotoxin sequestering agents.
    David SA; Sil D
    Subcell Biochem; 2010; 53():255-83. PubMed ID: 20593271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].
    Candel FJ; Martínez-Sagasti F; Borges M; Maseda E; Herrera-Gutiérrez M; Garnacho-Montero J; Maynar FJ; Zaragoza R; Mensa J; Azanza JR
    Rev Esp Quimioter; 2010 Sep; 23(3):115-21. PubMed ID: 20844841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the pathogenesis and therapy of sepsis and septic shock.
    Llewelyn M; Cohen J
    Curr Clin Top Infect Dis; 2001; 21():148-71. PubMed ID: 11572150
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nexus between systemic inflammation and disordered coagulation in sepsis.
    Opal SM
    J Endotoxin Res; 2004; 10(2):125-9. PubMed ID: 15120004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting endotoxin in the treatment of sepsis.
    Rachoin JS; Schorr CA; Dellinger RP
    Subcell Biochem; 2010; 53():323-38. PubMed ID: 20593274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
    David SA
    J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiendotoxin therapy in sepsis.
    Colletti RC; Dew RB; Goulart AE
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
    Andrä J; Gutsmann T; Garidel P; Brandenburg K
    J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septic shock; current pathogenetic concepts from a clinical perspective.
    Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J
    Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traumatic and septic shock alias post-trauma critical illness.
    Hardaway RM
    Br J Surg; 1998 Nov; 85(11):1473-9. PubMed ID: 9823905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic strategies in cases of septicemia caused by gram-negative bacteria].
    Łukasiewicz J; Ługowski C
    Postepy Hig Med Dosw; 2003; 57(3):251-62. PubMed ID: 14524245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic perspectives of severe infectious states].
    Offenstadt G; Guidet B; Barakett V
    Rev Prat; 1993 Jan; 43(1):59-64. PubMed ID: 8469900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.
    Horn DL; Morrison DC; Opal SM; Silverstein R; Visvanathan K; Zabriskie JB
    Clin Infect Dis; 2000 Oct; 31(4):851-8. PubMed ID: 11049761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.